This is an interesting video out a day ago: htt

Message Board

Previous

| Next

Post# of 152576

(Total Views: 417)

Posted On: 05/07/2025 4:22:40 PM

Posted By: DJknows

This is an interesting video out a day ago:

https://www.foxnews.com/health/terminal-colon...-treatment

Another article a week or so ago:

https://www.today.com/health/news/colon-cance...rcna203485

I don't have good sources and not sure about hearing that Crisper and Leronlimab are involved with the above. Anyone have anything on this?

AI has the following about Dr. Lou:

Quote:
AI Overview
Learn more
Dr. Emil Lou, a medical oncologist and neuro-oncologist at the University of Minnesota, is involved in clinical trials and research, including those related to CytoDyn Inc.'s leronlimab, a potential treatment for solid tumors. He is also a researcher leading a lab investigating colorectal cancer at the cellular and molecular levels.
Here's a more detailed look at Dr. Lou's work:
Clinical Trials:
.
Dr. Lou is actively involved in clinical trials, including one using CRISPR-based T cell therapy to treat metastatic gastrointestinal cancer. He is also part of a consortium working to develop a national clinical trial platform for colorectal cancer, K-SPY.
CytoDyn and Leronlimab:
.
Dr. Lou is involved in research and clinical trials related to CytoDyn Inc.'s leronlimab, a monoclonal antibody targeting the CCR5 receptor, which is being studied for its potential in solid-tumor oncology.
Neuroendocrine Cancer Research:
.
Dr. Lou specializes in neuroendocrine tumors and related GI NETs, pancreatic NETs, and liver metastasis. He also focuses on nuclear medicine techniques.
Gastrointestinal Cancers:
.
Dr. Lou provides care and treatment for patients with various gastrointestinal cancers, including colorectal cancer.
Research Focus:
.
His research focuses on understanding how cancer cells communicate and how this communication can be targeted to halt tumor growth, particularly in colorectal cancer. He also works to integrate new technologies like molecular diagnostics into treatment strategies.